Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral rivaroxaban on intestinal flora and its association with gastrointestinal bleeding in atrial fibrillation
ChiCTR2300075805Phase 4Recruiting
- Sponsor
- Suining Central Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by Suining Central Hospital. Primary endpoint: Intestinal flora composition. Started Jun 2022; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2300075805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075805.